US 10207003
Liquid pentablock co-polymer formulations for sustained delivery of therapeutics
granted A61KA61K31/415A61K31/542
Quick answer
US patent 10207003 (Liquid pentablock co-polymer formulations for sustained delivery of therapeutics) held by inovion, Inc. expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- inovion, Inc.
- Grant date
- Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/415, A61K31/542, A61K31/573, A61K31/635